Edmond DE Rothschild Holding S.A. Acquires 590 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Edmond DE Rothschild Holding S.A. raised its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 21.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,288 shares of the exchange traded fund’s stock after acquiring an additional 590 shares during the period. Edmond DE Rothschild Holding S.A.’s holdings in SPDR S&P Biotech ETF were worth $296,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of XBI. Howard Capital Management Group LLC lifted its stake in shares of SPDR S&P Biotech ETF by 2.6% in the 3rd quarter. Howard Capital Management Group LLC now owns 248,114 shares of the exchange traded fund’s stock valued at $24,514,000 after acquiring an additional 6,188 shares during the last quarter. FMR LLC increased its holdings in SPDR S&P Biotech ETF by 13.6% in the 3rd quarter. FMR LLC now owns 6,940 shares of the exchange traded fund’s stock worth $686,000 after purchasing an additional 830 shares in the last quarter. Glenmede Trust Co. NA raised its position in SPDR S&P Biotech ETF by 3.6% in the third quarter. Glenmede Trust Co. NA now owns 6,893 shares of the exchange traded fund’s stock valued at $681,000 after purchasing an additional 239 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of SPDR S&P Biotech ETF by 0.6% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 23,873 shares of the exchange traded fund’s stock valued at $2,373,000 after purchasing an additional 148 shares in the last quarter. Finally, Captrust Financial Advisors boosted its stake in shares of SPDR S&P Biotech ETF by 135.5% during the third quarter. Captrust Financial Advisors now owns 18,252 shares of the exchange traded fund’s stock valued at $1,803,000 after purchasing an additional 10,501 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

SPDR S&P Biotech ETF stock opened at $80.59 on Thursday. The business has a 50 day moving average of $88.81 and a 200-day moving average of $93.53. The company has a market capitalization of $5.08 billion, a P/E ratio of 11.47 and a beta of 1.00. SPDR S&P Biotech ETF has a 1 year low of $77.26 and a 1 year high of $105.47.

SPDR S&P Biotech ETF Cuts Dividend

The firm also recently declared a dividend, which was paid on Wednesday, March 26th. Shareholders of record on Monday, March 24th were given a $0.0053 dividend. The ex-dividend date of this dividend was Monday, March 24th.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.